First Commercial Cases with MISHA Knee System

Moximed marked the first commercial cases with MISHA, an implantable shock absorber for the knee.

The FDA-cleared MISHA Knee is indicated to treat people with medial knee osteoarthritis (OA) who failed to find relief from non-surgical or surgical treatment, continue to experience pain that interferes with daily activities, and are...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us